DNMDP is a potent and selective inhibitor of PDE3A and PDE3B, effectively eliminating cancer cells by promoting interactions between PDE3A/B and SFLN12, a critical protein in this process (Figure 3). The gene discussed is PDE3A; the disease is cancer.